Winter 2005 Newsletter kConFab Kathleen Cuningham Foundation CONsortium for research into FAmilial Breast Cancer Published by kConFab, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne 3002, phone

First Page		Document Content
Date: 2007-01-14 19:57:32 Risk factors for breast cancer BRCA mutation Ovarian cancer Cancer BRCA1 Prostate cancer Mammography Menopause Aromatase inhibitor Medicine Oncology Breast cancer		Winter 2005 Newsletter kConFab Kathleen Cuningham Foundation CONsortium for research into FAmilial Breast Cancer Published by kConFab, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne 3002, phone Add to Reading List Source URL: www.kconfab.org Download Document from Source Website File Size: 1,45 MB Share Document on Facebook

	Prediction of 10-year distant recurrence (DR) using the Prosigna® (PAM50) test in a Danish Breast Cancer Cooperative Group (DBCG) cohort of postmenopausal Danish women with hormone receptor-positive (HR+) early breast c DocID: 1qXDq - View Document
	RESEARCH ARTICLE DEVICES Droplet-Scale Estrogen Assays in Breast Tissue, Blood, and Serum Noha A. Mousa,1,2* Mais J. Jebrail,2,3* Hao Yang,3 Mohamed Abdelgawad,4 DocID: 1kK0S - View Document
	Both omega-3, placebo help with aromatase inhibitor-induced pain DocID: 1dXtC - View Document
	Enzyme that converts testosterone to estrogen has big role in the healthy, injured brain DocID: 1aDXc - View Document
	Winter 2005 Newsletter kConFab Kathleen Cuningham Foundation CONsortium for research into FAmilial Breast Cancer Published by kConFab, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne 3002, phone DocID: 18N0O - View Document